These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15664329)

  • 1. High-performance liquid chromatography measurement of hyperforin and its reduced derivatives in rodent plasma.
    Rozio M; Fracasso C; Riva A; Morazzoni P; Caccia S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):21-7. PubMed ID: 15664329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of hypericin and hyperforin in human plasma with liquid chromatography-tandem mass spectrometry.
    Riedel KD; Rieger K; Martin-Facklam M; Mikus G; Haefeli WE; Burhenne J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):27-33. PubMed ID: 15556512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-drop liquid-phase microextraction for the determination of hypericin, pseudohypericin and hyperforin in biological fluids by high performance liquid chromatography.
    Gioti EM; Skalkos DC; Fiamegos YC; Stalikas CD
    J Chromatogr A; 2005 Nov; 1093(1-2):1-10. PubMed ID: 16233865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of hyperforin, hypericin, and pseudohypericin in human plasma using high-performance liquid chromatography analysis with fluorescence and ultraviolet detection.
    Bauer S; Störmer E; Graubaum HJ; Roots I
    J Chromatogr B Biomed Sci Appl; 2001 Dec; 765(1):29-35. PubMed ID: 11817306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of hyperforin in mouse brain by high-performance liquid chromatography/tandem mass spectrometry.
    Keller JH; Karas M; Müller WE; Volmer DA; Eckert GP; Tawab MA; Blume HH; Dingermann T; Schubert-Zsilavecz M
    Anal Chem; 2003 Nov; 75(22):6084-8. PubMed ID: 14615985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of hyperforin in human plasma using solid-phase extraction and high-performance liquid chromatography with ultraviolet detection.
    Cui Y; Gurley B; Ang CY; Leakey J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(1):129-35. PubMed ID: 12383488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers.
    Biber A; Fischer H; Römer A; Chatterjee SS
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():36-43. PubMed ID: 9684946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation of hyperforin in Hypericum montbretii during its phenological cycle.
    Cirak C; Radusiene J
    Nat Prod Res; 2007 Nov; 21(13):1151-6. PubMed ID: 17987494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrahydrohyperforin and octahydrohyperforin are two new potent inhibitors of angiogenesis.
    Martínez-Poveda B; Verotta L; Bombardelli E; Quesada AR; Medina MA
    PLoS One; 2010 Mar; 5(3):e9558. PubMed ID: 20224821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a high-performance liquid chromatographic method with electrochemical detection for the determination of hyperforin.
    Rückert U; Eggenreich K; Wintersteiger R; Wurglics M; Likussar W; Michelitsch A
    J Chromatogr A; 2004 Jul; 1041(1-2):181-5. PubMed ID: 15281267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Air/light-free hyphenated extraction/analysis system: supercritical fluid extraction on-line coupled with liquid chromatography-UV absorbance/electrospray mass spectrometry for the determination of hyperforin and its degradation products in Hypericum pertoratum.
    Wang Z; Ashraf-Khorassani M; Taylor LT
    Anal Chem; 2004 Nov; 76(22):6771-6. PubMed ID: 15538802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet.
    Schulz HU; Schürer M; Bässler D; Weiser D
    Arzneimittelforschung; 2005; 55(1):15-22. PubMed ID: 15727160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural investigations of isomeric oxidised forms of hyperforin by HPLC-NMR and HPLC-MSn.
    Wolfender JL; Verotta L; Belvisi L; Fuzzati N; Hostettmann K
    Phytochem Anal; 2003; 14(5):290-7. PubMed ID: 14516001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fast high-performance liquid chromatographic analysis of naphthodianthrones and phloroglucinols from Hypericum perforatum extracts.
    Tolonen A; Hohtola A; Jalonen J
    Phytochem Anal; 2003; 14(5):306-9. PubMed ID: 14516003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain Uptake of Tetrahydrohyperforin and Potential Metabolites after Repeated Dosing in Mice.
    Fracasso C; Bagnati R; Passoni A; Guiso G; Cantoni L; Riva A; Morazzoni P; Gobbi M
    J Nat Prod; 2015 Aug; 78(8):2029-35. PubMed ID: 26287496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of phloroglucinol in human plasma by gas chromatography-mass spectrometry.
    Lartigue-Mattei C; Lauro-Marty C; Bastide M; Berger JA; Chabard JL; Goutay E; Aiache JM
    J Chromatogr; 1993 Jul; 617(1):140-6. PubMed ID: 8376528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers.
    Schulz HU; Schürer M; Bässler D; Weiser D
    Arzneimittelforschung; 2005; 55(10):561-8. PubMed ID: 16294501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral bioavailability of active principles from herbal products in humans. A study on Hypericum perforatum extracts using the soft gelatin capsule technology.
    Agrosi M; Mischiatti S; Harrasser PC; Savio D
    Phytomedicine; 2000 Dec; 7(6):455-62. PubMed ID: 11194173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aristoforin, a novel stable derivative of hyperforin, is a potent anticancer agent.
    Gartner M; Müller T; Simon JC; Giannis A; Sleeman JP
    Chembiochem; 2005 Jan; 6(1):171-7. PubMed ID: 15593112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer and Antibacterial Activity of Hyperforin and Its Derivatives.
    Pia Schiavone BI; Verotta L; Rosato A; Marilena M; Gibbons S; Bombardelli E; Franchini C; Corbo F
    Anticancer Agents Med Chem; 2014; 14(10):1397-1401. PubMed ID: 25173557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.